Status:
UNKNOWN
Identification and Preservation of Arm Lymphatics
Lead Sponsor:
Wuhan University
Conditions:
Breast Cancer Related Lymphedema
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Controversy in axillary reverse mapping in axillary lymph node dissection (ALND) possibly results from incomplete recognition of the arm lymphatic system (ALS) and its compromise to oncological safety...
Eligibility Criteria
Inclusion
- Patients aged 18 years or older with T1-3 invasive breast cancer;
- Clinically node-positive breast cancer, defined as positive on preoperative axillary palpation, ultrasound examination, and computed tomography scan with contrast;
- Patients who underwent mastectomy with a positive sentinel lymph node (SLN);
- Patients who underwent breast-conserving surgery containing more than two positive SLNs.
Exclusion
- Neoadjuvant chemotherapy;
- Previous history of breast cancer.
Key Trial Info
Start Date :
June 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04446494
Start Date
June 20 2020
End Date
September 30 2025
Last Update
December 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071